What is the longest lasting benzodiazepine (benzo)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Longest Lasting Benzodiazepine

Diazepam is the longest lasting benzodiazepine, with a half-life of up to 100 hours and active metabolites that can persist in the body for even longer periods. 1

Pharmacokinetics of Long-Acting Benzodiazepines

Benzodiazepines can be classified based on their elimination half-life:

  1. Long-acting benzodiazepines (half-life up to 100 hours):

    • Diazepam
    • Nitrazepam
    • Flurazepam
    • Bromazepam 1
  2. Intermediate-acting benzodiazepines (half-life up to 30 hours):

    • Oxazepam
    • Lorazepam
    • Flunitrazepam
    • Temazepam 1
  3. Short-acting benzodiazepines (half-life up to 8 hours):

    • Triazolam
    • Nidazolam 1

The National Cancer Institute notes that long-acting benzodiazepines are characterized by half-lives longer than 24 hours, pharmacologically active metabolites, accumulation with multiple dosages, and impaired clearance in older patients and those with liver disease 2.

Clinical Implications of Long-Acting Benzodiazepines

Long-acting benzodiazepines like diazepam have several important clinical considerations:

  • Accumulation risk: The extended half-life and active metabolites (particularly N-desmethyldiazepam) lead to drug accumulation with repeated dosing 3
  • Tolerance development: Long-acting benzodiazepines with significant accumulation of active metabolites (like ketazolam) show high degrees of tolerance development 4
  • Elderly patients: Long-acting benzodiazepines pose particular risks in elderly patients due to increased sensitivity to sedative effects, higher risk of falls and fractures, cognitive impairment, and delirium 5

Therapeutic Applications Based on Duration

The duration of action influences the appropriate clinical use:

  • Long-acting benzodiazepines (like diazepam) are generally preferred for:

    • Treatment of sustained levels of anxiety
    • Anticonvulsant therapy
    • Situations requiring continuous treatment 3, 6
  • Short-acting benzodiazepines are generally preferred for:

    • Insomnia (action restricted to nighttime)
    • Episodic anxiety 3, 6

Cautions and Recommendations

  • The American Geriatrics Society recommends avoiding long-term benzodiazepine use in elderly patients altogether 5
  • If benzodiazepines are necessary, the American Academy of Sleep Medicine recommends choosing shorter-acting agents like lorazepam over longer-acting ones like clonazepam for elderly patients 5
  • For any benzodiazepine use, prescriptions should ideally be limited to short-term use (maximum 4 weeks) 5, 7
  • Regular reassessment of continued need for benzodiazepines is crucial, with evaluation at least every 2-4 weeks 5

Pitfalls to Avoid

  • Long-term dependence: Long-acting benzodiazepines carry significant risk of dependence, with approximately 50% of patients continuing treatment for at least 12 months contrary to guidelines 5
  • Respiratory depression: Concomitant use with opioids increases risk of severe respiratory depression and death 5
  • Cognitive effects: Long-acting benzodiazepines can cause significant cognitive impairment, especially in elderly patients 5
  • Withdrawal symptoms: Abrupt discontinuation after prolonged use can lead to significant withdrawal symptoms that may persist for months to years 4

In summary, while diazepam is the longest-lasting benzodiazepine with half-life up to 100 hours, this extended duration of action carries both therapeutic advantages for certain conditions and significant risks that must be carefully considered, particularly in vulnerable populations.

References

Research

[Chemical and pharmacologic aspects of benzodiazepines].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The natural history of tolerance to the benzodiazepines.

Psychological medicine. Monograph supplement, 1988

Guideline

Benzodiazepine Use in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Short-term versus long-term benzodiazepine therapy.

Current medical research and opinion, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.